Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release-Reference-Cited by-同舟云学术

Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release

Published:2012-12 Issue:52 Volume:287 Page:43685-43693
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Destouches Damien,Huet Eric,Sader Maha,Frechault Sophie,Carpentier Gilles,Ayoul Florie,Briand Jean-Paul,Menashi Suzanne,Courty José

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference40 articles.

1. Illuminating the metastatic process;Sahai;Nat. Rev. Cancer,2007

2. Matrix metalloproteinases as modulators of inflammation and innate immunity;Parks;Nat. Rev. Immunol.,2004

3. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome;Ara;J. Pediatr. Surg.,1998

4. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma;Ribatti;Life Sci.,2001

5. Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma;Sakakibara;Cancer,1999

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review);International Journal of Molecular Medicine;2023-07-21

2. Emerging application of magnetic nanoparticles for breast cancer therapy;European Polymer Journal;2023-04

3. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression;Cancers;2022-08-31

4. Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells;European Journal of Pharmaceutics and Biopharmaceutics;2022-03

5. Nxhl Controls Angiogenesis by Targeting VE-PTP Through Interaction With Nucleolin;Frontiers in Cell and Developmental Biology;2021-10-11